229 related articles for article (PubMed ID: 9691019)
1. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.
Tomita N; Horiuchi M; Tomita S; Gibbons GH; Kim JY; Baran D; Dzau VJ
Am J Physiol; 1998 Aug; 275(2):F278-84. PubMed ID: 9691019
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.
Tomita N; Kim JY; Gibbons GH; Zhang L; Kaneda Y; Stahl RA; Ogborn M; Venderville B; Morishita R; Baran D; Dzau VJ
Int J Mol Med; 2004 May; 13(5):629-36. PubMed ID: 15067361
[TBL] [Abstract][Full Text] [Related]
3. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP.
Park KK; Deok Ahn J; Lee IK; Magae J; Heintz NH; Kwak JY; Lee YC; Cho YS; Kim HC; Chae YM; Ho Kim Y; Kim CH; Chang YC
Biochem Biophys Res Commun; 2003 Sep; 308(4):689-97. PubMed ID: 12927774
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates.
Kawauchi M; Suzuki J; Morishita R; Wada Y; Izawa A; Tomita N; Amano J; Kaneda Y; Ogihara T; Takamoto S; Isobe M
Circ Res; 2000 Nov; 87(11):1063-8. PubMed ID: 11090553
[TBL] [Abstract][Full Text] [Related]
6. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.
Maeshima Y; Kashihara N; Yasuda T; Sugiyama H; Sekikawa T; Okamoto K; Kanao K; Watanabe Y; Kanwar YS; Makino H
J Clin Invest; 1998 Jun; 101(11):2589-97. PubMed ID: 9616230
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition on phenotypic transformation of detrusor smooth muscle cells after bladder outlet obstruction by E2F decoy strategy].
Gong Y; Du CJ; Ding LL; Song B; Jin XY
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):829-32. PubMed ID: 17565867
[TBL] [Abstract][Full Text] [Related]
9. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events.
Beier R; Bürgin A; Kiermaier A; Fero M; Karsunky H; Saffrich R; Möröy T; Ansorge W; Roberts J; Eilers M
EMBO J; 2000 Nov; 19(21):5813-23. PubMed ID: 11060032
[TBL] [Abstract][Full Text] [Related]
10. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
Ahn JD; Morishita R; Kaneda Y; Kim HS; Chang YC; Lee KU; Park JY; Lee HW; Kim YH; Lee IK
Gene Ther; 2002 Dec; 9(24):1682-92. PubMed ID: 12457282
[TBL] [Abstract][Full Text] [Related]
11. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
13. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
Afshari CA; Nichols MA; Xiong Y; Mudryj M
Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
[TBL] [Abstract][Full Text] [Related]
14. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
15. E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis.
Tomita T; Kunugiza Y; Tomita N; Takano H; Morishita R; Kaneda Y; Yoshikawa H
Int J Mol Med; 2006 Aug; 18(2):257-65. PubMed ID: 16820932
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
17. Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide.
Yoshida M; Yamamoto N; Nitta T; Uehara T; Terao R; Hatano E; Iimuro Y; Yamaoka Y
J Surg Res; 2002 Feb; 102(2):95-101. PubMed ID: 11796004
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of E2F-1 by cyclin A-cdk2.
Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
[TBL] [Abstract][Full Text] [Related]
19. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Lees E; Faha B; Dulic V; Reed SI; Harlow E
Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067
[TBL] [Abstract][Full Text] [Related]
20. Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells.
Hosokawa Y; Yang M; Kaneko S; Tanaka M; Nakashima K
Biochem Mol Biol Int; 1995 Oct; 37(2):393-9. PubMed ID: 8673024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]